Dental Anaesthetic · Canada · 2026

Dental Anaesthetic in Canada — 2026 Clinical Guide

Informational Guide · Updated March 2026 · Canada

Informational purposes only. This page provides general market information about dental supplies in Canada. It does not constitute procurement advice. CanadianDentalSupplies.com is a premium domain name available for acquisition — not an active dental supply company.

Overview

Dental Local Anaesthetics in Canada

Local anaesthetics are among the most critical and consistently purchased clinical supplies in any Canadian dental practice. Every invasive dental procedure — from a simple extraction to complex implant surgery — requires effective local anaesthesia. Canada’s dental anaesthetic market is tightly regulated by Health Canada and governed by provincial drug scheduling and prescribing regulations.

Dental local anaesthetics in Canada are supplied in 1.7ml or 1.8ml glass cartridges (carpules) designed for use with standard dental syringes. The most commonly used agents are lidocaine, articaine, mepivacaine and prilocaine, each available in various concentrations and with or without vasoconstrictors (epinephrine/adrenaline).

Local Anaesthetic Agents

Common Dental Anaesthetics Used in Canada

Regulatory Note: Dental local anaesthetic cartridges are regulated as Schedule F prescription drugs under Health Canada’s Food and Drug Regulations. They may only be purchased by or for licensed dental practitioners and must be stored and handled according to applicable drug storage regulations in each province.

Delivery Systems

Anaesthetic Delivery Equipment

Market Data

Canadian Dental Anaesthetic Market 2026

ProductCommon Brands in CanadaNotes
Lidocaine 2% + Epi 1:100kXylocaine, LidodanMost widely used agent
Articaine 4% + Epi 1:100kSeptanest, AstracaineGrowing market share
Mepivacaine 3%Carbocaine, ScandonestNo vasoconstrictor option
Prilocaine 4%CitanestLower toxicity profile
Topical AnaestheticHurricaine, Topex, CetacainePre-injection surface use
27g/30g NeedlesSeptodont, TerumoHigh-volume consumable
CDCP Impact

CDCP & Anaesthetic Demand

The CDCP’s expansion of dental access has directly increased anaesthetic consumption at participating Canadian practices. More patient appointments, particularly for restorative and extraction procedures among previously uninsured populations, translate to proportionally higher consumption of local anaesthetic cartridges and needles — two of the highest-volume consumables in any active dental practice.

Premium Domain — Available Now
CanadianDentalSupplies.com
Canada’s #1 dental supply domain. Exact-match .com — instant acquisition via Spaceship.

Frequently Asked Questions

The most commonly used agents are lidocaine 2% with epinephrine 1:100,000, articaine 4% with epinephrine, mepivacaine 3% (without vasoconstrictor) and prilocaine 4%. Bupivacaine is used for long-acting post-operative pain control in oral surgery.
Yes. Dental local anaesthetic cartridges are regulated as Schedule F prescription drugs under Health Canada’s Food and Drug Regulations. They may only be purchased by or for licensed dental practitioners and are not available to the general public.
Articaine 4% with epinephrine is valued for its superior diffusion through bone tissue, making it particularly effective for mandibular infiltration injections where other agents may require block anaesthesia. Its market share in Canada has grown significantly over the past decade.
Septodont (Septanest, Scandonest), AstraZeneca (Xylocaine, Citanest), Pfizer (Carbocaine) and generic manufacturers supply dental anaesthetic cartridges in Canada. All major national dental distributors including Henry Schein Canada and Patterson Dental carry comprehensive anaesthetic ranges.